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er than on CF (0.26 ± 0.17 mm 2 vs. 0.13 ± 0.1 mm 2 , p < 0.0001). 
The CWS area on SD-OCT and surrounding pathology such 
as intraretinal cysts, avascular zones and intraretinal hemor-
rhage were predictive for how long CWS remained visible 
(r 2  = 0.497, p < 0.002).  Conclusions: The lifetime and presen-
tation of CWS in BRVO seem comparable to other diseases. 
SD-OCT shows a higher sensitivity for detecting CWS com-
pared to CF. The duration of visibility of CWS varies among 
different image modalities and depends on the surrounding 
pathology and the CWS size.  © 2015 S. Karger AG, Basel 
 Introduction 
 Cotton wool spots (CWS) are not specific for a disease, 
but rather a sign of vascular damage  [1] . Ischemia due to 
vasoconstriction or occlusive events as well as mechanical 
pressure affecting the superficial capillary network locat-
ed in the retinal nerve fiber layer (RNFL) may induce 
CWS. In turn, ischemic events of the intermediate and 
deep capillary network may induce paracentral middle 
maculopathy and acute macular neuroretinopathy. His-
tologically, CWS consist of accumulated cystoid bodies, 
which represent the terminal swelling of a disrupted gan-
glion cell axon with accumulated axonal debris  [2, 3] .
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 Abstract 
 Purpose: To describe and follow cotton wool spots (CWS) in 
branch retinal vein occlusion (BRVO) using multimodal  im-
aging.  Methods: In this prospective cohort study including 
24 patients with new-onset BRVO, CWS were described and 
analyzed in color fundus photography (CF), spectral domain 
optical coherence tomography (SD-OCT), infrared (IR) and 
fluorescein angiography (FA) every 3 months for 3 years. The 
CWS area on SD-OCT and CF was evaluated using OCT-Tool-
Kit software: CWS were marked in each single OCT B-scan 
and the software calculated the area by interpolation.  Re-
sults: 29 central CWS lesions were found. 100% of these CWS 
were visible on SD-OCT, 100% on FA and 86.2% on IR imag-
ing, but only 65.5% on CF imaging. CWS were visible for 
12.4 ± 7.5 months on SD-OCT, for 4.4 ± 3 months and 4.3 ± 
3.4 months on CF and on IR, respectively, and for 17.5 ± 7.1 
months on FA. The evaluated CWS area on SD-OCT was larg-
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 CWS reveal a characteristic presentation on each im-
age device. On color fundus photographs (CF) or by oph-
thalmoscopy, CWS appear as fluffy whitish lesions with 
frayed edges  [1] . In fluorescein angiography (FA), 90% of 
the lesions appear hyperfluorescent and the remaining 
10% appear hypofluorescent in the early phase and be-
come hyperfluorescent in the late phase  [4] . In optical co-
herence tomography (OCT), CWS appear as hyperreflec-
tive lesions in the retinal RNFL  [5] . On average, CWS dis-
appear within 7–12 weeks from ophthalmoscopic view, 
although they have been found to be still visible on OCT 
after vanishing from CF images  [5–7] . After resolution on 
OCT, CWS often leave ganglion cell layer, RNFL and in-
ner nuclear layer thinning, and functionally CWS resolu-
tion is associated with persistent relative scotomas  [8, 9] .
 CWS have been methodically studied in HIV, diabetic 
macular edema, central retinal vein occlusion and hyper-
tension, but so far not in branch retinal vein occlusion 
(BRVO)  [8–13] . The aim of this study was to assess and 
describe CWS in BRVO in a longitudinal setting over 
3 years using multimodal imaging.
 Methods 
 Patient Selection and Setting 
 30 eyes of 30 patients with new-onset BRVO, who were re-
cruited for a prospective nonrandomized study at the Department 
of Ophthalmology, Medical University Vienna, were evaluated 
 [14] . The study adhered to the tenets of the Declaration of Hel-
sinki, was approved by the Ethics Committee of the Medical Uni-
versity of Vienna and all patients gave informed consent. Inclu-
sion criteria were the confirmed diagnosis of treatment-naïve 
acute BRVO with a decrease of visual acuity and a central retinal 
thickness >300 μm. Patients received one intravitreal ranibizum-
ab (Lucentis; Novartis, Basel, Switzerland) injection at baseline, 
followed by an ‘as needed’ regimen (treatment was repeated when 
central retinal thickness increased >50 μm compared with the pre-
vious visit or when BCVA decreased >5 letters). Study visits in the 
first year were scheduled on a monthly basis followed by 3-month 
intervals for the next 2 years. Segmental argon laser coagulation 
was performed in patients with an avascular zone of more than 5 
papillary diameters and recurrent macular edema on FA, and af-
ter sufficient clearance of intraretinal hemorrhage. Patients were 
followed up for 3 years (for further details regarding study design 
see ‘Ranibizumab in patients with branch retinal vein occlusions’, 
ClinicalTrials.gov Identifier: NCT01027481, https://clinicaltrials.
gov/ct2/show/NCT01027481).
 Patients who had had BRVO longer than 8 weeks before the 
start of the study were not included to assure a homogeneous 
group of CWS with recent onset. CF, FA, infrared (IR) and spectral 
domain (SD)-OCT imaging were performed and evaluated at 
baseline and thereafter at 3-month intervals for 3 years. The num-
ber of ranibizumab injections and argon laser coagulation laser 
treatments were recorded.
 Image Acquisition and Evaluation 
 Spectralis SD-OCT (Heidelberg Engineering, Heidelberg, 
 Germany) volume scans and IR images (37 high-resolution scans, 
distance between scans 124 μm, 30 ART frames, 20 × 15, Heidel-
berg Engineering, Software 1.7.0.0) were evaluated at baseline and 
every 3 months thereafter. Scans at exactly the same retinal loca-
tion were generated at each visit using the follow-up function. FA 
was performed with a Heidelberg retina angiograph (HRA 2, Hei-
delberg Engineering) and 2- and 10-min images were chosen for 
evaluation. CF photographs were taken with the Zeiss FF450 Fun-
dus Camera (Carl Zeiss Meditec).
 A software program (OCT-Tool-Kit) developed at the  Vienna 
Reading Center was used to compare, measure and describe the 
CWS in the different image modalities  [15, 16] . SD-OCT and 
corresponding IR pictures were loaded in XML format, and 
FA and CF pictures were loaded in BMP format. Three easily 
detectable points in the IR picture and the corresponding points 
in the FA or CF picture were chosen with the OCT-Tool-Kit 
software. Then, CF and FA pictures were superimposed exactly 
over the IR images. The XML format included additional image 
information (e.g. pixel/μm) provided by the OCT manufacturer, 
which enables the software to compare the BMP pictures (thus 
CF and FA images) directly and 1: 1 to the SD-OCT-images, ir-
respective of their individual original magnifications. This al-
lows a direct 1: 1 comparison of appearance and size. The CWS 
were then marked in every single OCT B-scan. The software 
projected the marked areas in the en-face IR picture, calculating 
the CWS area by interpolation. Hereby, the manually marked 
CWS areas in the B-scan and the mean distance between the 
 B-scans (0.012 mm in the 37-line scan) together with the XML 
file software calibration were used to calculate the area of each 
CWS. The area in CF photographs was evaluated in the same 
way by uploading BMP images and manually marking affected 
areas in every  B-scan.
 Due to the exact overlay, a qualitative and quantitative point-
to-point comparison of the size, expanse, morphology and appear-
ance of CWS in SD-OCT and the corresponding imaging devices 
was possible. A CWS was defined as present in SD-OCT when a 
homogenous plaque of intensive hyperreflectivity at the neuronal 
layer and underneath was associated with a focal epiretinal eleva-
tion in at least one B-scan  [5] . The subsequent thinning of the 
RNFL, ganglion cell layer and inner nuclear layer was not graded 
as presence of a CWS  [9] . A CWS was graded as present in CF im-
ages when a circumscribed, whitish, fluffy lesion with frayed edges 
was seen  [1] . A CWS was graded as present on IR images when a 
well-demarcated whitish hyperreflective roundish lesion corre-
sponding to the hyperreflective RNFL thickening in SD-OCT or 
the fluffy whitish lesion on CF images was present. A CWS was 
graded as present on FA when a well-demarcated hypo/hyperfluo-
rescent lesion corresponding to the presence of a CWS in SD-OCT 
and/or CF images was present ( fig. 1 ).
 Statistical Analyses 
 Statistical analyses were performed using SPSS 21 (SPSS Inc., 
Chicago, Ill., USA) software. Data were evaluated descriptively and 
numeric values were indicated as the mean ± SD. Differences in 
terms of size were evaluated with a paired t test. Factors associated 
with the duration of visibility of CWS were analyzed using a mul-
tivariate regression analysis. p  ≤ 0.05 was deemed statistically sig-
nificant.
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 Results 
 Demographic Characteristics 
 Out of the 30 patients, 24 patients (12 men, 12 women, 
mean age: 66 ± 11 years, 4 inferotemporal and 20 supero-
temporal BRVOs) presented with BRVO with an onset 
 ≤ 8 weeks before the screening visit and were included in 
the study for further evaluation. Out of these 24 eyes, 18 
eyes (75%) showed one or more CWS within the raster 
scan area (mean: 1.8 ± 1.3 CWS, range: 1–5) per eye. Over-
all, 29 CWS lesions within the SD-OCT scan area were 
found and analyzed at baseline. During the 3-year obser-
vational period, 3 additional CWS appeared in 3 different 
patients. A representative example of the presentation of a 
CWS in respective imaging devices can be found in  figure 
1 .  Figure 2 shows the corresponding marked areas. The 
average number of ranibizumab injections per patient was 
4.5 ± 3.7 (range: 1–13) over the 3-year period. Out of the 
24 patients, 6 (5 presenting with CWS, 1 not) received 
 segmental argon laser coagulation laser treatment (mean: 
1.7 ± 0.7, range: 1–3) during the observational period.
 Morphologic and Angiographic Appearance of CWS 
 All 29 CWS (100%) were visible on SD-OCT, but only 
19 (65.5%) were visible on the CF images at baseline. 25 
(86.2%) of the CWS lesions showed corresponding chang-
es on the IR image. All 29 (100%) CWS lesions showed 
corresponding fluorescent changes on FA: 9 (31%) 
 Fig. 1. CWS at baseline in  FA in a 2-min 
phase ( a ) and in a 10-min phase ( b ), CF ( c ), 
IR ( d ) and SD-OCT ( e ). In SD-OCT the 
indicated CWS (arrow) presented as a ho-
mogenous plaque of intensive hyperreflec-
tivity in the neuronal layer. In CF the CWS 
appeared as a circumscribed, whitish, fluffy 
lesion with frayed edges. In IR, the CWS 
presented as a well-demarcated whitish hy-
perreflective roundish lesion, correspond-
ing to the hyperreflective nerve fiber layer 
thickening in SD-OCT or the fluffy whitish 
lesion in CF. In FA, the corresponding 
CWS area was either hypofluorescent, hy-
perfluorescent, or hypofluorescent and be-
came hyperfluorescent in the late phase. 
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showed hypofluorescent lesions, 4 (13.8%) hyperfluores-
cent lesions, and the majority, 16 (55.2%), hypofluores-
cent changes at 2 min and hyperfluorescent changes at 
10 min. At baseline, 27 (92.1%) CWS were surrounded by 
blood visible on CF images, 23 (78.3%) by intraretinal 
cysts visible on OCT, 2 (6.9%) by subretinal fluid and 1 by 
an avascular zone visible on FA.
 CWS on FA could change their fluorescent behavior 
on FA as the fluorescence seemed to be associated with 
the surrounding pathology: CWS in the near vicinity of 
intraretinal cysts were mainly hyperfluorescent (88%), 
CWS surrounded by intraretinal hemorrhage were either 
hypofluorescent (41%) or hypofluorescent in the early 
phase and hyperfluorescent in late phase (44%), and CWS 
within an avascular zone presented mostly (83%) as hy-
pofluorescent on FA.
 Size and Duration of Visibility 
 The mean area of CWS for each imaging method is 
shown in  table 1 . The mean area of a CWS in SD-OCT 
was larger than on the CF image (paired t test: 0.26 ± 0.17 
mm 2 vs. 0.13 ± 0.1, p  ≤ 0.0001). The CWS area evaluated 
by the OCT-Tool-Kit software on SD-OCT (but not on 
CF), and surrounding pathology such as intraretinal 
cysts, avascular zones and intraretinal hemorrhage were 
predictive for how long a CWS remained visible (r²  = 
 Fig. 2. The different marked areas of the 
CWS in SD-OCT (corresponding to fig. 1), 
FA and CF evaluated by the OCT-Tool Kit 
software. CWS were marked in each OCT 
B-scan ( a ), and the marked area was then 
projected en-face on the IR picture ( b ) and 
the affected area was automatically calcu-
lated by interpolation. The CWS (arrow) 
was 0.14 mm 2 in SD-OCT ( c ) 0.09 mm 2 in 
CF (arrow) ( d ) and the corresponding 
CWS area in FA revealed 0.17 mm 2 .  
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0.497, p < 0.002). Large CWS surrounded by intraretinal 
hemorrhage were visible longer than smaller CWS in the 
near vicinity of intraretinal cysts and avascular zones.
 CWS were visible for 12.4 ± 7.5 months (range: 1–30) 
on SD-OCT, but only for 4.4 ± 3.2 months (range: 1–12) 
on CF images. Representative examples can be found in 
 figures 3 ,  4 and  5 . Corresponding CWS lesions on IR im-
ages were visible for 4.3 ± 3.4 months (range: 1–12) while 
corresponding fluorescent changes on FA were visible 
longer than the CWS itself on SD-OCT (mean: 17.5 ± 7.1 
months, range: 3–27). However, after the 15-month fol-
low-up, the margins of the CWS on FA became very in-
distinct and the lesions were only discernable from their 
surroundings with the use of an overlay.
 Discussion 
 To the best of our knowledge this is the first study to 
evaluate the appearance of CWS in a very homogeneous 
group of patients with BRVO using four different imag-
ing modalities in a longitudinal manner. Although CWS 
have been described in different diseases, including 
CRVO, only a few case reports have addressed the ap-
pearance and behavior of CWSs in BRVO so far  [13, 17] . 
The current study reveals that SD-OCT aims to be a sen-
sitive tool to detect small CWS even when they are invis-
ible on CF, and it demonstrates that the duration of visi-
bility of CWS seems to differ dependent on image modal-
ity and appears to be associated with the size of a CWS 
and with the surrounding pathology.
 Currently, the main clinical image modality to observe 
CWS is CF photography. This study, however, shows that 
only 65.5% of all examined CWS were detectable on CF, 
whereas all CWS were visible on SD-OCT and FA. Fur-
ther, the area of a CWS was larger on SD-OCT compared 
to CF. Previous studies have already demonstrated that 
CWS are visible longer on OCT than by ophthalmoscopy 
 [2, 9] . The higher prevalence of CWS on SD-OCT may 
therefore be a result of the longer duration of visibility. It 
may also be possible that a CWS has to reach a certain size 
to be clearly visible by ophthalmoscopy.
 Many previous studies have evaluated the mean ‘life-
time’ of CWS in funduscopy in different kinds of retinal 
diseases. These studies showed they were visible any-
where from 4 weeks to 17.2 months depending on under-
lying disease, patient’s age and medication  [12, 13, 18] . 
Besides these factors, our analysis revealed that the area 
of CWS as well as the surrounding pathology such as in-
traretinal cysts, intraretinal hemorrhage and avascular 
zones seem to be factors associated with the duration of 
visibility. On average, CWS were visible on CF images for 
4.4 months in our study, which is right in the middle of 
previous findings. However, CWS were visible three 
times longer in SD-OCT than on CF images and IR, with 
a mean of 12 months. Previous studies have already 
shown that CWS are visible longer on OCT than on CF 
images and that the hyperreflectivity of the CWS lesions 
decreases gradually on OCT  [5, 9] . Similar to CF, the 
presence of CWS was shorter on IR than on OCT. 
 CWS result from ischemic events at the level of the su-
perficial capillary network and present as hyporeflective 
lesions on IR and as localized hyperreflectivity and thick-
ening of the RNFL on OCT. This presentation corre-
sponds to the appearance of acute macular neuroretinop-
athy and paracentral middle maculopathy lesions on IR 
and SD-OCT, which are thought to be induced by vasooc-
clusive events at the level of the intermediate and deep 
retinal capillary network, and are therefore sometimes re-
ported as ‘deep CWS’  [19–21] . However, unlike the cur-
rent finding in CWS that the hyperreflectivity on OCT 
was visible longer than the hyporeflectivity on IR, acute 
macular neuroretinopathy and paracentral middle macu-
lopathy lesions were reported to diminish simultaneous-
ly in respective imaging devices  [19–22] . This discrep-
ancy may be due to the fact that the CWS we examined 
were mainly found near other pathologies such as cysts, 
avascular zones or intraretinal hemorrhage, which may 
 Table 1.  Mean calculated area of CWS in BVRO in SD-OCT, CF 
and FA
Visits, 
months
SD-OCT, μm2 CF, μm2 FA, μm2
Baseline 0.22±0.16 0.12±0.09 0.27±0.29
3 0.19±0.13 0.08±0.05 0.25±0.21
6 0.18±1.9 0.17±0.12 0.3±0.22
9 0.09±0.07 0.06 0.12±0.1
12 0.08±0.03 0.03 0.12±0.7
15 0.08±0.07 0.03 0.29±0.47
18 0.09±0.06 n.a. n.a.
21 0.06±0.04 n.a. n.a.
24 0.06±0.04 n.a. n.a.
27 0.1±0.06 n.a. n.a.
30 0.1 n.a. n.a.
33 n.a. n.a. n.a.
36 n.a. n.a. n.a.
 Values are given as means ± SD. Area of CWS on FA was eval-
uated until month 15. After that, the margins of CWS on FA were 
too blurry to allow accurate area evaluation.
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aggravate the evaluation of the CWS in different image 
devices and alter their presentation and behavior.
 Interestingly, CWS remained visible for 17.5 ± 7.1 
months on FA, longer than on SD-OCT. Previous stud-
ies have described superficial capillary nonperfusion 
with vascular leakage and staining in the late phase to 
correspond to the CWS on FA in the acute phase  [21] . 
In the chronic phase, CWS were mainly described as in-
visible on FA or detectable as an indistinct hypofluores-
cent area, visible due to the leakage from the surround-
ing perfused capillaries  [21] . In our study, CWS were 
detectable on FA longer than on SD-OCT. It has to be 
taken into account, however, that hyperreflectivity and 
thickening of the RNFL, but not the ensuing localized 
atrophy of the RNFL, was graded as CWS on SD-OCT 
and that during follow-up the margins of the CWS on 
 Fig.  3. Representative CWS in CF ( a–d ) 
and SD-OCT ( e–h ) during follow-up. 
 a  Baseline (size: 0.09 mm 2 ).  b 3 months af-
ter initial presentation, the area is even big-
ger compared to baseline (area: 0.15 mm 2 ). 
 c 6 months after initial presentation, CWS 
is no longer visible in CF. d 24 months after 
initial presentation.  e Axoplasmic debris in 
the RNFL at baseline (area: 0.14 mm 2 ). 
 f   Hyperreflective axoplasmic debris 
3  months after initial presentation (area: 
0.28 mm 2 ).  g 6 months after initial presen-
tation,  homogenous hyperreflective plaque 
is still visible in SD-OCT (area: 0.09 mm 2 ). 
 h 24 months after initial presentation, hy-
perreflective plaque has given way to inner 
retinal layer atrophy.  
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FA became very indistinct and the lesion was only dis-
cernable from the surroundings when an overlay was 
used. It seems reasonable that the affected area remains 
distinguishable for a long period of time on FA as it re-
sembles an area of capillary nonperfusion which re-
mains nonperfused  [21] .
 Indeed, the surrounding pathology together with the 
size of a CWS has an impact on the duration of visibility. 
Large CWS surrounded by intraretinal hemorrhage were 
visible longer than smaller CWS close to intraretinal cysts 
or an ischemic zone. The surrounding pathology not only 
affected the duration of visibility, but also influenced the 
fluorescent behavior of a CWS. In previous reports, CWS 
in FA were mainly described as hyperfluorescent lesions 
with late staining and leakage around their margins  [1, 10, 
13, 23] . Lesions that were hypofluorescent in the early 
 Fig. 4. Another example of the presentation 
of a CWS in CF ( a–c ) and SD-OCT ( d–f ). 
 a Baseline (area: 0.22 mm 2 ).  b 6 months af-
ter initial presentation, the CWS has faded 
but is still visible (area: 0.1 mm 2 ).  c 12 
months after initial presentation, the CWS 
is no longer visible in CF.  d Axoplasmic de-
bris in the RNFL at baseline (area: 0.3 
mm 2 ).  e After 6 months:  besides the atro-
phy of the inner retinal layers, a hyperre-
flective sign is still visible (area: 0.13 mm 2 ). 
 f After 12 months:  concordant to the CF-
images, the hyperreflective sign faded and 
the atrophy of the inner retinal layers re-
mains. 
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phase but became hyperfluorescent in the late phase were 
suggested to be a sign of ischemia and were observed in a 
study with experimental retinal ischemia  [4] . In the cur-
rent study, CWS were either hyperfluorescent or hypo-
fluorescent in the early and late phases or hypofluores-
cent in the early phase and hyperfluorescent in the late 
phase. Their fluorescent behavior changed over time and 
was associated with the surrounding pathology: CWS 
surrounded by an avascular zone or by intraretinal hem-
orrhage presented as hypofluorescent and either re-
mained hypofluorescent or became hyperfluorescent in 
the late phase due to staining and leakage. CWS sur-
rounded by intraretinal cysts and edema, however, main-
ly presented as hyperfluorescent in the early and late 
phases. The discrepancies between the presentation of 
CWS on FA in experimental retinal ischemia and in 
BRVO in the current study may be due to different find-
ings in the area surrounding a CWS or due to different 
underlying pathologies. However, both have in common 
that hypofluorescent rather than pure hyperfluorescent 
CWS lesions seem to be a sign of hypoperfusion and isch-
emia. Intraretinal hemorrhage and focal ischemia were 
pathologies often described in close vicinity to CWS  [23, 
24] , and since intraretinal hemorrhage is associated with 
local ischemia and often results in inner retinal atrophy, 
intraretinal hemorrhage could therefore be a concrete 
sign of the presence and the development of an avascular 
zone with similar results as an avascular zone in a hypo-
fluorescent lesion.
 In summary, this study indicates that the ‘lifetime’ of 
CWS in BRVO seems comparable to other diseases and 
that the duration of visibility of CWS varies among dif-
 Fig. 5. Another example of the presentation 
of a CWS in CF ( a–c ) and SD-OCT ( d–f ). 
 a  Baseline (area: 0.22 mm 2 ).  b 6 months af-
ter initial presentation: the CWS area is 
even bigger compared to baseline (area: 
0.28 mm 2 ).  c 12 months after initial presen-
tation: CWS is no longer visible in CF. 
 d  Axoplasmic debris in RNFL at baseline 
(area: 0.51 mm 2 ).  e 6 months: the CWS area 
has increased in size (area: 0.79 mm 2 ).  f 18 
months:  a hyperreflective sign is still visible 
(area: 0.17 mm 2 ). 
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ferent image modalities and depends on the surrounding 
pathology and the size of the CWS. Overall, SD-OCT 
seems to be a precise tool to detect, measure and observe 
central CWS, and it may be more sensitive in the detec-
tion of a CWS than CF.
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